TechnologyTwo Chinese biotech firms sign $2.5b global drug deals Sridhar POctober 23, 2025October 23, 202501 mins The drug candidate is an antibody-drug conjugate aimed at a molecule linked to gastrointestinal cancers. Post navigation Previous: Wonder Studios Raises $12M From Backers Including Atomico & AdobeNext: How Europe Is Trying to Turn Frozen Russian Assets Into Cash for Ukraine Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
Anthropic’s Claude Managed Agents gives enterprises a new one-stop shop but raises vendor ‘lock-in’ risk April 15, 2026April 15, 2026
A Harvard economist calculated exactly how much the Iran war will cost U.S. taxpayers—and it’s staggering April 14, 2026April 14, 2026
